Napredna pretraga

Pregled bibliografske jedinice broj: 743386

Compliance of blood sampling procedures with the CLSI H3-A6 guidelines : An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG- PRE)


Šimundić, Ana-Maria; Church, Stephen; Cornes, Michael; Grankvist, Kjell; Lippi, Giuseppe; Nybo, Mads; Nikolac, Nora; van Dongen-Lases, Edmee; Eker, Pinar; Kovalevskaya, Svetlana et al.
Compliance of blood sampling procedures with the CLSI H3-A6 guidelines : An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG- PRE) // Clinical chemistry and laboratory medicine, 53 (2015), 9; 1321-1331 doi:10.1515/cclm-2014-1053 (međunarodna recenzija, članak, znanstveni)


Naslov
Compliance of blood sampling procedures with the CLSI H3-A6 guidelines : An observational study by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG- PRE)

Autori
Šimundić, Ana-Maria ; Church, Stephen ; Cornes, Michael ; Grankvist, Kjell ; Lippi, Giuseppe ; Nybo, Mads ; Nikolac, Nora ; van Dongen-Lases, Edmee ; Eker, Pinar ; Kovalevskaya, Svetlana ; Kristensen, Gunn Berit Berge ; Sprongl, Ludek ; Sumarac, Zorica

Izvornik
Clinical chemistry and laboratory medicine (1434-6621) 53 (2015), 9; 1321-1331

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Phlebotomy; quality; preanalytical phase

Sažetak
Background: An observational study was conducted in 12 European countries by the European Federation of Clinical Chemistry and Laboratory Medicine Working Group for the Preanalytical Phase (EFLM WG-PRE) to assess the level of compliance with the CLSI H3-A6 guidelines. Methods: A structured checklist including 29 items was created to assess the compliance of European phlebotomy procedures with the CLSI H3-A6 guideline. A risk occurrence chart of individual phlebotomy steps was created from the observed error frequency and severity of harm of each guideline key issue. The severity of errors occurring during phlebotomy was graded using the risk occurrence chart. Results: Twelve European countries participated with a median of 33 (18 – 36) and a total of 336 audits. The median error rate for the total phlebotomy procedure was 26.9 (10.6 – 43.8), indicating a low overall compliance with the recommended CLSI guideline. Patient identification and test tube labelling were identified as the key guideline issues with the highest combination of probability and potential risk of harm. Administrative staff did not adhere to patient identification procedures during phlebotomy, whereas physicians did not adhere to test tube labelling policy. Conclusions: The level of compliance of phlebotomy procedures with the CLSI H3-A6 guidelines in 12 European countries was found to be unacceptably low. The most critical steps in need of immediate attention in the investigated countries are patient identification and tube labelling.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
134-1340227-0200 - Upala i udio farmakogenetike u razvoju i ishodu akutnih i kroničnih bolesti (Ana-Maria Šimundić, )

Ustanove
KBC "Sestre Milosrdnice"

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati